Home / Site Map Site Map Pages Home BOLSTER Clinical Trial Patients & Families Cholangiocarcinoma (Bile Duct Cancer) Signs, Symptoms and Treatment Head and Neck Cancer Signs, Symptoms and Treatment Metastatic Pancreatic Ductal Adenocarcinoma Symptoms, Signs & Treatment Research & Technology CendR Platform® – Targeted penetration technology to enhance drug delivery to advanced solid tumors CD34+ Cell Technology Publications About Us Management Team Board of Directors Pipeline Advanced Solid Tumors – LSTA1 Careers Contact Us Clinical Trials Privacy Policy Pipeline Programs Temozolomide with LSTA1 or placebo (Estonia/Latvia) LSTA1 + Hyperthermic intraperitoneal chemotherapy intraoperative intraperitoneal lavage (U.S.) Durvalumab, gemcitabine/nab-paclitaxel + LSTA1 (Australia) Management Tariq Imam Kristen K. Buck, MD James Nisco John D. Menditto Gail Holler Gregory S. Berkin David J. Mazzo, PhD Board Of Directors Mohammad Azab, MD, MSc, MBA Heidi Henson Cynthia L. Flowers Steven M. Klosk Gregory B. Brown, MD David J. Mazzo, PhD